Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The current status and future prospects of treatment for multiple myeloma.

× No keyword cloud information.

13 in total

1. Multiple myeloma.

Authors: R M Meyer
Journal: Can Fam Physician Date: 1985-06 Impact factor: 3.275

2. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.

Authors: Patric Kröpil; Roland Fenk; Lars B Fritz; Dirk Blondin; Guido Kobbe; Ulrich Mödder; Mathias Cohnen
Journal: Eur Radiol Date: 2007-10-09 Impact factor: 5.315

3. The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma.

Authors: U Loos; E Musch; M Engel; J H Hartlapp; E Hügl; H J Dengler
Journal: Eur J Clin Pharmacol Date: 1988 Impact factor: 2.953

4. Treatment of refractory multiple myeloma with the vincristine-adriamycin-dexamethasone (VAD) regimen.

Authors: W Stenzinger; A Blömker; W Hiddemann; J van de Loo
Journal: Blut Date: 1990 Aug-Sep

5. Bulky extramedullary plasmacytomata: rare mode of relapse in myelomatosis.

Authors: S V Davies; B Jones; C M Starkie; J A Murray
Journal: J Clin Pathol Date: 1989-03 Impact factor: 3.411

6. Marrow cytometry and prognosis in myeloma.

Authors: B Barlogie; R Alexanian; E A Gehan; L Smallwood; T Smith; B Drewinko
Journal: J Clin Invest Date: 1983-09 Impact factor: 14.808

7. Vincristine and oral etoposide in refractory multiple myeloma.

Authors: R K Ganjoo; A Williams; J S Malpas
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

8. Increased plasma viscosity as a reason for inappropriate erythropoietin formation.

Authors: A Singh; K U Eckardt; A Zimmermann; K H Götz; M Hamann; P J Ratcliffe; A Kurtz; W H Reinhart
Journal: J Clin Invest Date: 1993-01 Impact factor: 14.808

9. Cytostatic drug sensitivity test for human multiple myeloma, measuring monoclonal immunoglobulin produced by bone marrow cells in vitro.

Authors: D Peest; B Bartels; I Dallmann; I Schedel; H Deicher
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

10. Thalidomide and its analogues in the treatment of Multiple Myeloma.

Authors: Tahir Latif; Nabeel Chauhan; Rashid Khan; Andrea Moran; Saad Z Usmani
Journal: Exp Hematol Oncol Date: 2012-09-11